Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 47 | 52 | +5 |
| Shares | 25.9M | 25.9M | −50.0K (−0.2%) |
| Value | $3.37M | $5.61M | +$2.23M (+66.3%) |
New holders (11)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 317,621 | $68.7K | 0.06% |
| Virtu Financial LLC | 162,885 | $35.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 119,367 | $25.8K | 0.00% |
| Two Sigma Securities, LLC | 19,089 | $4.13K | 0.00% |
| Bayesian Capital Management, LP | 18,800 | $4.07K | 0.00% |
| Susquehanna International Group, LLP | 13,755 | $2.97K | 0.00% |
| FMR LLC | 3,500 | $757 | 0.00% |
| Advisory Services Network, LLC | 2,000 | $432 | 0.00% |
| Rothschild Investment LLC | 660 | $143 | 0.00% |
| Bank of America Corp | 272 | $58 | 0.00% |
| McGlone Suttner Wealth Management, Inc. | 22 | $5 | 0.00% |
Sold out (6)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 754,732 | $98.1K |
| Squarepoint Ops LLC | 148,065 | $19.2K |
| Jane Street Group, LLC | 34,503 | $4.49K |
| Baader Bank INC | 33,544 | $3.77K |
| Magnus Financial Group LLC | 10,000 | $1.30K |
| SlateStone Wealth, LLC | 10,000 | $1.00K |